BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37878196)

  • 1. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation.
    Fu X; Iglesias-Álvarez D; García-Campos A; Martínez-Monzonís MA; Almenglo C; Martinez-Cereijo JM; Reija L; Fernandez ÁL; Gonzalez-Juanatey JR; Rodriguez-Manero M; Eiras S
    J Cardiovasc Transl Res; 2024 Feb; 17(1):13-23. PubMed ID: 37878196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure.
    Koduri H; Ng J; Cokic I; Aistrup GL; Gordon D; Wasserstrom JA; Kadish AH; Lee R; Passman R; Knight BP; Goldberger JJ; Arora R
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):640-9. PubMed ID: 22722658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial fat in atrial fibrillation and heart failure.
    Iacobellis G; Zaki MC; Garcia D; Willens HJ
    Horm Metab Res; 2014 Jul; 46(8):587-90. PubMed ID: 24557503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
    Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.
    Packer M
    Cardiovasc Diabetol; 2019 Sep; 18(1):121. PubMed ID: 31551089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrail fibrillation and heart failure: a complex relationship].
    Costantini M; Ranieri AT; Fachechi C; Tritto C; Sticchi G
    G Ital Cardiol (Rome); 2006 Jan; 7(1):40-9. PubMed ID: 16528961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation in the presence and absence of heart failure enhances expression of genes involved in cardiomyocyte structure, conduction properties, fibrosis, inflammation, and endothelial dysfunction.
    Zeemering S; Isaacs A; Winters J; Maesen B; Bidar E; Dimopoulou C; Guasch E; Batlle M; Haase D; Hatem SN; Kara M; Kääb S; Mont L; Sinner MF; Wakili R; Maessen J; Crijns HJGM; Fabritz L; Kirchhof P; Stoll M; Schotten U
    Heart Rhythm; 2022 Dec; 19(12):2115-2124. PubMed ID: 36007727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
    Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
    Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between cardiac fibrosis and permanent atrial fibrillation in advanced heart failure.
    Aldhoon B; Kučera T; Smorodinová N; Martínek J; Melenovský V; Kautzner J
    Physiol Res; 2013; 62(3):247-55. PubMed ID: 23489193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome activation in end-stage heart failure-associated atrial fibrillation.
    Kugler S; Onódi Z; Ruppert M; Sayour AA; Oláh A; Benke K; Ferdinandy P; Merkely B; Radovits T; Varga ZV
    ESC Heart Fail; 2022 Aug; 9(4):2747-2752. PubMed ID: 35585786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.
    Sun LY; Qu X; Chen LZ; Chen XX; Zheng GS; Wang ZT; Huang WJ; Zhou H
    Heart Vessels; 2017 Dec; 32(12):1506-1512. PubMed ID: 28689282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
    Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
    JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of atrial electrograms in a pacing-induced heart failure model of atrial fibrillation: importance of regional atrial connexin40 remodeling.
    Hsieh MH; Lin YJ; Wang HH; Lo LW; Chang SL; Yan YL; Chou TY; Chen SA; Yeh HI
    J Cardiovasc Electrophysiol; 2013 May; 24(5):573-82. PubMed ID: 23421445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A temporal window of vulnerability for development of atrial fibrillation with advancing heart failure.
    Burashnikov A; Di Diego JM; Sicouri S; Doss MX; Sachinidis A; Barajas-Martínez H; Hu D; Minoura Y; Sydney Moise N; Kornreich BG; Chi L; Belardinelli L; Antzelevitch C
    Eur J Heart Fail; 2014 Mar; 16(3):271-80. PubMed ID: 24464846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.
    Nezami Z; Holm H; Ohlsson M; Molvin J; Korduner J; Bachus E; Zaghi A; Dieden A; Platonov PG; Jujic A; Magnusson M
    Front Cardiovasc Med; 2022; 9():982871. PubMed ID: 36337899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation and heart failure: a dangerous criminal conspiracy].
    Piot O
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S14-6. PubMed ID: 20103171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Santema BT; Arita VA; Sama IE; Kloosterman M; van den Berg MP; Nienhuis HLA; Van Gelder IC; van der Meer P; Zannad F; Metra M; Ter Maaten JM; Cleland JG; Ng LL; Anker SD; Lang CC; Samani NJ; Dickstein K; Filippatos G; van Veldhuisen DJ; Lam CSP; Rienstra M; Voors AA
    Cardiovasc Res; 2022 Aug; 118(11):2478-2487. PubMed ID: 34687289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and heart failure.
    Larned JM; Raja Laskar S
    Congest Heart Fail; 2009; 15(1):24-30. PubMed ID: 19187404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
    Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.